High development costs refer to the substantial financial investments required to research, develop, and bring a new drug to market. This concept is especially relevant in the context of orphan drugs, which are developed for rare diseases affecting small patient populations. Due to limited market potential, companies often face significant financial risks when investing in orphan drugs, as the costs associated with clinical trials, regulatory approvals, and post-market surveillance can be prohibitively high.
congrats on reading the definition of high development costs. now let's actually learn it.